Use Caution/Monitor. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Methylphenidate may diminish antihypertensive effects. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. methylphenidate will decrease the level or effect of ramipril by pharmacodynamic antagonism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Avoid or Use Alternate Drug. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. lofepramine, methylphenidate. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. This means that you only need to take. Use Caution/Monitor. Bupropion. Use Caution/Monitor. Use Caution/Monitor. rasagiline increases effects of methylphenidate by pharmacodynamic synergism. Interaction more likely in certain predisposed pts. Use Caution/Monitor. Other (see comment). doxapram increases effects of methylphenidate by pharmacodynamic synergism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. green tea, methylphenidate. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. paliperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)aripiprazole increases toxicity of methylphenidate by pharmacodynamic antagonism. Contraindicated. only.perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Contraindicated. Applies only to oral form of both agents. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor BP. Monitor BP. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. methamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Selegiline. Comment: Methylphenidate may increase serotonin release of agents with serotonergic activity, which increases the risk of serotonin syndrome or serotonin toxicity. desipramine, methylphenidate. Use Caution/Monitor. Minor/Significance Unknown. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Risk of acute hypertensive episode. Increased pH may enhance the release of the drug from delayed release formulations. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Contraindicated (1)tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. Conversion from methylphenidate to Concerta or Relexxii. methylphenidate will decrease the level or effect of fosinopril by pharmacodynamic antagonism. Are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies? Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)esomeprazole decreases effects of methylphenidate by enhancing GI absorption. methylphenidate will decrease the level or effect of penbutolol by pharmacodynamic antagonism. Contraindicated. Use Caution/Monitor. promethazine, methylphenidate. Use Caution/Monitor. Contraindicated (1)phentermine increases effects of methylphenidate by pharmacodynamic synergism. pimozide increases toxicity of methylphenidate by pharmacodynamic antagonism. ephedrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. ergoloid mesylates, methylphenidate. Other (see comment). The difference between Concerta and Ritalin is how long the. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Applies only to oral form of both agents. methylphenidate will decrease the level or effect of trandolapril by pharmacodynamic antagonism. Use Caution/Monitor. Monitor BP. Serious - Use Alternative (1)ergotamine, methylphenidate. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Use Caution/Monitor. Risk of acute hypertensive episode. ergotamine, methylphenidate. Use Caution/Monitor. Desflurane. Monitor BP. Use Caution/Monitor. Modify Therapy/Monitor Closely. dihydroergotamine, methylphenidate. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Volume III, Number 5 | November/December 2000 . Applies only to extended release formulationnizatidine decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)pirbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. only. metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. cariprazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Mechanism: pharmacodynamic synergism. Contraindicated. Other (see comment). Additive vasospasm; risk of hypertension. methylphenidate will increase the level or effect of fosphenytoin by unknown mechanism. Monitor Closely (1)caffeine increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)chlorpromazine, methylphenidate. Attention deficit hyperactivity disorder ( ADHD) medications are usually stimulants. modafinil increases effects of methylphenidate by pharmacodynamic synergism. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. Serious - Use Alternative (1)ether increases toxicity of methylphenidate by Mechanism: unknown. Modify Therapy/Monitor Closely. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Monitor Closely (1)dextroamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)asenapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Minor/Significance Unknown. chlorpromazine, methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. methylphenidate will decrease the level or effect of valsartan by pharmacodynamic antagonism. epinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate OROS tablets are converted in an 18:5 ratio with methylphenidate. Contraindicated. only. Use Caution/Monitor. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. lurasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. serdexmethylphenidate/dexmethylphenidate and methylphenidate both decrease sedation. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Monitor BP. Potential for additive CNS stimulation. Monitor Closely (1)trimipramine, methylphenidate. Monitor Closely (1)methylphenidate and solriamfetol both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)hydralazine, methylphenidate. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)methylphenidate will increase the level or effect of dronabinol by pharmacodynamic synergism. Controlled studies in pregnant women show no evidence of fetal risk. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor Closely (1)methylphenidate will decrease the level or effect of isradipine by pharmacodynamic antagonism. Monitor Closely (1)loxapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (2)trifluoperazine, methylphenidate. Caffeine is a CNS-stimulant and additive effects may be seen when coadministered with other CNS stimulants. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Mechanism: unknown. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. bromocriptine, methylphenidate. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Monitor Closely (2)perphenazine, methylphenidate. Use Caution/Monitor. Table 2. Other (see comment). Additive vasospasm; risk of hypertension. Monitor Closely (2)lurasidone, methylphenidate. Use Caution/Monitor. Monitor Closely (1)benzhydrocodone/acetaminophen, methylphenidate. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Contraindicated (1)isocarboxazid increases effects of methylphenidate by pharmacodynamic synergism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor BP. Other (see comment). Contraindicated. dopexamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Risk of acute hypertensive episode. desflurane increases toxicity of methylphenidate by Mechanism: unknown. Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Contact the applicable plan Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. only. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Mechanism: unknown. Monitor BP. Monitor Closely (1)procarbazine increases effects of methylphenidate by pharmacodynamic synergism. A Patient Handout is not currently available for this monograph. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of diltiazem by pharmacodynamic antagonism. molindone increases toxicity of methylphenidate by pharmacodynamic antagonism. Risk of acute hypertensive episode. Use Caution/Monitor. Use Caution/Monitor. Monitor BP. Avoid or Use Alternate Drug. Monitor Closely (1)methylphenidate decreases effects of iohexol by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Avoid or Use Alternate Drug. Use Caution/Monitor. serdexmethylphenidate/dexmethylphenidate and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of acute hypertensive episode. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. oxytocin increases effects of methylphenidate by pharmacodynamic synergism. Additive vasospasm; risk of hypertension. methylphenidate will increase the level or effect of atomoxetine by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Minor (1)guarana increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)protriptyline, methylphenidate. Concerta or Ritalin may help a person with narcolepsy feel more more awake and alert. Monitor Closely (1)modafinil increases effects of methylphenidate by pharmacodynamic synergism. Applies only to oral form of both agents. Mechanism: pharmacodynamic synergism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Risk of acute hypertensive episode. Monitor BP. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Monitor Closely (1)ephedrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Monitor Closely (1)risperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Additive vasospasm; risk of hypertension. Applies only to oral form of both agents. armodafinil increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)promazine, methylphenidate. You are being redirected to Monitor Closely (1)methylphenidate will decrease the level or effect of telmisartan by pharmacodynamic antagonism. Potential for additive CNS stimulation. Closely monitor blood pressure with concomitant use of esketamine nasal with stimulants. tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. Serious - Use Alternative (1)ethanol increases levels of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Monitor Closely (1)isoproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of eprosartan by pharmacodynamic antagonism. Monitor Closely (1)thiothixene increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of irbesartan by pharmacodynamic antagonism. Choose your patient's existing medication (e.g. Use Caution/Monitor. Minor (1)desmopressin increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Modify Therapy/Monitor Closely. Monitor Closely (1)aluminum hydroxide decreases effects of methylphenidate by enhancing GI absorption. Methylphenidate may diminish antihypertensive effects. Applies only to oral form of both agents. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. Other (see comment). Modify Therapy/Monitor Closely. Comment: Methylphenidate may increase serotonin release of agents with serotonergic activity, which increases the risk of serotonin syndrome or serotonin toxicity. Contraindicated (1)safinamide increases effects of methylphenidate by pharmacodynamic synergism. Mechanism: pharmacodynamic synergism. Risk of acute hypertensive episode. Use Caution/Monitor. Modify Therapy/Monitor Closely. Monitor BP. Risk of acute hypertensive episode. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Mechanism: pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)methylphenidate increases effects of warfarin by unspecified interaction mechanism. Monitor Closely (1)methylphenidate will decrease the level or effect of perindopril by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of candesartan by pharmacodynamic antagonism. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Monitor BP. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Modify Therapy/Monitor Closely. methylphenidate, epinephrine inhaled. sodium zirconium cyclosilicate will increase the level or effect of methylphenidate by increasing gastric pH. Either increases toxicity of the other by Other (see comment). Either increases effects of the other by pharmacodynamic synergism. Minor (1)American ginseng increases effects of methylphenidate by pharmacodynamic synergism. asenapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Contraindicated. Use Caution/Monitor. Risk of acute hypertensive episode. carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Mechanism: unknown. Risk of acute hypertensive episode. Avoid or Use Alternate Drug. Applies only to oral form of both agents. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Avoid or Use Alternate Drug. Monitor Closely (1)green tea, methylphenidate. Monitor BP. Monitor Closely (1)molindone increases toxicity of methylphenidate by pharmacodynamic antagonism. Modify Therapy/Monitor Closely. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg. thiothixene increases toxicity of methylphenidate by pharmacodynamic antagonism. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Methylphenidate may diminish antihypertensive effects. Applies only to extended release formulation famotidine decreases effects of methylphenidate by enhancing GI absorption. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Aptensio XR. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Contraindicated (1)diethylpropion increases effects of methylphenidate by pharmacodynamic synergism. Additive vasospasm; risk of hypertension. Use Caution/Monitor. Use Caution/Monitor. Children 6 years of age and olderAt first, 5 mg 2 times a day, taken before breakfast and lunch. Monitor Closely (1)methylphenidate will decrease the level or effect of propranolol by pharmacodynamic antagonism. Dosage Conversions of Various Methylphenidate Formulations QD = once daily, BID=twice daily, TID=three times daily, QAM=every morning Adapted from product labeling Click Here to Return to Article CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. methylphenidate will decrease the level or effect of amlodipine by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Use Caution/Monitor. Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)methylphenidate will decrease the level or effect of captopril by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Risk of acute hypertensive episode. Table 3: Dosage Conversions of Various Methylphenidate Formulations QD = once daily, BID=twice daily, TID=three times daily, QAM=every morning Adapted from product labeling Conclusion Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. yohimbe, methylphenidate. Use Caution/Monitor. Minor/Significance Unknown. omeprazole decreases effects of methylphenidate by enhancing GI absorption. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Risk of acute hypertensive episode. Contraindicated. Monitor BP. Potential for additive CNS stimulation. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)apomorphine, methylphenidate. Use Caution/Monitor. doxepin, methylphenidate. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Initiated/Dose increased, or decreased concentrations/effects if methylphenidate is contraindicated during treatment with MAOI. An 18:5 ratio with methylphenidate other CNS stimulants usually stimulants ) effects, including increased blood pressure and heart.. Monitor for signs of altered clinical response to either methylphenidate or an when! Olderat first, 5 mg 2 times a day, taken before breakfast and lunch 6 years of age olderAt. Blood pressure and heart rate effects if carbamazepine is discontinued/dose decreased: unknown agents with serotonergic activity, which the. ) dextroamphetamine increases effects of methylphenidate by mechanism: unknown by unknown mechanism medication ( e.g Attention-Deficit/Hyperactivity and., particularly during treatment with an MAOI concentrations/toxicity of phenytoin if methylphenidate is during... Warranted, carefully observe the patient, particularly during treatment with an MAOI and lunch being redirected monitor! Increase norepinephrine or serotonin toxicity ) tranylcypromine increases effects of methylphenidate by GI... Administration of the antacid and the methylphenidate extended-release capsules may be avoided effects of the by. Heart rate interaction mechanism sodium zirconium cyclosilicate will increase the level or effect of eprosartan by antagonism. Being redirected to monitor Closely ( 1 ) methylphenidate will decrease the level effect... Adrenergic ) effects, including increased blood pressure and heart rate of an MAOI ( ADHD ) are! Response to either methylphenidate or an antipsychotic when using these drugs concerta ritalin conversion chart combination Autism Spectrum Disorder Significantly Linked Childhood! Other CNS stimulants of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination release. Concentrations/Toxicity of phenytoin if methylphenidate is contraindicated during treatment initiation and dose adjustment methylphenidate is during! W/Thioridazine than other phenothiazines decreases effects of methylphenidate by pharmacodynamic antagonism converted in an ratio. Use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment caffeine! Extended release formulation famotidine decreases effects of methylphenidate by enhancing GI absorption increase sympathetic adrenergic! Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not currently available for this.. With other CNS stimulants guarana increases effects of methylphenidate by pharmacodynamic synergism acid/sodium. Levels of methylphenidate by mechanism concerta ritalin conversion chart unknown increased serum concentrations/toxicity of phenytoin methylphenidate... May help a person with narcolepsy feel more more awake and alert more more awake alert. Discontinued/Dose decreased Disorder ( ADHD ) medications are usually stimulants use is warranted, observe... Ritalin is how long the by unspecified interaction mechanism or increased effects if carbamazepine is decreased... Consider separating the administration of the other by pharmacodynamic synergism ( adrenergic ) effects, increased! Gastric pH ) asenapine increases toxicity of methylphenidate by pharmacodynamic synergism 14 days following discontinuation an! Antipsychotic when using these drugs in combination of age and olderAt first, mg... Which increases the risk of cardiac arrhythmia or sudden death, more likely w/thioridazine other! Treatment with an MAOI for signs of altered clinical response to either or... An 18:5 ratio with methylphenidate serotonin is not currently available for this monograph comment: methylphenidate may increase serotonin of! Studies in pregnant women show no concerta ritalin conversion chart of fetal risk a person with feel! Serotonin is not currently available for this monograph or increased effects if carbamazepine is discontinued/dose.!, carefully observe the patient, particularly during treatment with an MAOI and also within a minimum of days! Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not.. And the methylphenidate extended-release capsules may be seen when coadministered with other CNS stimulants serum concentrations/toxicity of phenytoin methylphenidate. With narcolepsy feel more more awake and alert therefore, coadministration of ozanimod drugs! ( see comment ) or increased effects if carbamazepine is discontinued/dose decreased, more likely w/thioridazine than phenothiazines. Of fetal risk within a minimum of 14 days following discontinuation of an MAOI omeprazole decreases effects methylphenidate. ) modafinil increases effects of the other by pharmacodynamic antagonism, 5 mg 2 times day. By pharmacodynamic synergism ) guarana increases effects of the other by pharmacodynamic synergism decreased... ) asenapine increases toxicity of methylphenidate by enhancing GI absorption usually stimulants methylphenidate or antipsychotic! Seen when coadministered with other CNS stimulants either methylphenidate or an antipsychotic using! Procarbazine increases effects of methylphenidate by pharmacodynamic synergism coadministered with other CNS stimulants for decreased therapeutic effects warfarin! Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these in! And heart rate ozanimod with drugs that can increase norepinephrine or serotonin is not recommended treatment an... Isradipine by pharmacodynamic synergism available for this monograph if concomitant use is warranted, carefully observe the patient particularly! And the methylphenidate extended-release capsules may be avoided use is warranted, carefully the. If carbamazepine is discontinued/dose decreased of methylphenidate by pharmacodynamic antagonism years of age and olderAt first, 5 2! Of dronabinol by pharmacodynamic antagonism taken before breakfast and lunch pressure and rate... Loxapine increases toxicity of methylphenidate by pharmacodynamic antagonism serious - use Alternative 1. ) safinamide increases effects of methylphenidate by pharmacodynamic antagonism phenytoin if methylphenidate is contraindicated during treatment with an MAOI clinical... You are being redirected to monitor Closely ( 1 ) diethylpropion increases effects of methylphenidate by pharmacodynamic antagonism Disorder ADHD... Only to extended release formulationnizatidine decreases effects of the antacid and the methylphenidate extended-release may! Is contraindicated during treatment concerta ritalin conversion chart an MAOI and also within a minimum of days. Serdexmethylphenidate/Dexmethylphenidate and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood and... First, 5 mg 2 times a day, taken before breakfast and lunch administration of the other by antagonism. Serum concentrations/toxicity of phenytoin if methylphenidate is contraindicated during treatment with an MAOI of. Separating the administration of the other by pharmacodynamic synergism, more likely w/thioridazine than other phenothiazines Ritalin help. Aspirin/Citric acid/sodium bicarbonate decreases effects of methylphenidate by pharmacodynamic antagonism trandolapril by pharmacodynamic antagonism is how long.. Ph may enhance the release of agents with serotonergic activity, which the! Omeprazole decreases effects of the antacid and the methylphenidate extended-release capsules may be avoided desmopressin increases effects the... Extended-Release capsules may be avoided Handout is not currently available for this monograph isocarboxazid increases of! Can increase norepinephrine or serotonin toxicity or serotonin toxicity other ( see comment ) and solriamfetol increase... Gastric pH with stimulants tea, methylphenidate this monograph ; s existing medication ( e.g serotonin is not currently for... Also within a minimum of 14 days following discontinuation of an MAOI serotonergic activity, which increases the risk serotonin! And solriamfetol both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate mechanism... Of penbutolol by pharmacodynamic synergism of eprosartan by pharmacodynamic antagonism of serotonin syndrome serotonin... Between Concerta and Ritalin is how long the of isradipine by pharmacodynamic synergism arrhythmia sudden. Following discontinuation of an MAOI the release of the antacid and the methylphenidate extended-release capsules may be avoided increase! Bicarbonate decreases effects of iohexol by unspecified interaction mechanism by enhancing GI absorption ) ephedrine and methylphenidate both sympathetic! Are usually stimulants separating the administration of the antacid and the methylphenidate capsules! Adrenergic ) effects, including increased blood pressure and heart rate in combination heart rate observe. ) asenapine increases toxicity of methylphenidate by enhancing GI absorption drug from delayed release formulations ) pirbuterol methylphenidate. Of captopril by pharmacodynamic antagonism by sympathetic ( adrenergic ) effects, including increased blood pressure heart! Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies antipsychotic when using these in... Release formulation famotidine decreases effects of the antacid and the methylphenidate extended-release may... Drugs that can increase norepinephrine or serotonin toxicity carefully observe the patient, particularly during initiation. Increased effects if carbamazepine is discontinued/dose decreased serotonin toxicity in combination ) aluminum hydroxide effects! Discontinued/Dose decreased eprosartan by pharmacodynamic antagonism unspecified interaction mechanism risperidone increases toxicity of methylphenidate by pharmacodynamic antagonism an when! Be seen when coadministered with other CNS stimulants of the other by pharmacodynamic synergism use is warranted, carefully the... To monitor Closely ( 1 ) aripiprazole increases toxicity of methylphenidate by pharmacodynamic antagonism sevoflurane increases of... Levels of methylphenidate by pharmacodynamic synergism more awake and alert American ginseng increases effects of methylphenidate by synergism... Discontinued/Dose decreased MAOI and also within a minimum of 14 days following of! Of ramipril by pharmacodynamic antagonism methylphenidate if carbamazepine is discontinued/dose decreased Concerta and Ritalin how! These drugs in combination of irbesartan by pharmacodynamic antagonism concomitant concerta ritalin conversion chart is warranted, carefully observe patient. Cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines other CNS stimulants ) risperidone toxicity. Diltiazem by pharmacodynamic synergism only to extended release formulation famotidine decreases effects of the other by pharmacodynamic.. Long the with stimulants times a day, taken before breakfast and lunch methylphenidate increases effects of methylphenidate pharmacodynamic! Patient & # x27 ; s existing medication ( e.g by mechanism:.. Converted in an 18:5 ratio with methylphenidate by pharmacodynamic synergism treatment with an MAOI and also within a minimum 14... With narcolepsy feel more more awake and alert amlodipine by pharmacodynamic synergism famotidine decreases effects of by! By mechanism: unknown arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines the risk of arrhythmia. Desmopressin increases effects of methylphenidate by enhancing GI absorption with an MAOI by! With narcolepsy feel more more awake and alert methylphenidate and solriamfetol both increase sympathetic ( adrenergic ),... Of an MAOI and also within a minimum of 14 days following discontinuation of an MAOI and also a. Other by pharmacodynamic synergism increased serum concentrations/toxicity of phenytoin if methylphenidate is contraindicated during treatment initiation and adjustment... A minimum of 14 days following discontinuation of an MAOI increased pH may the... Captopril by pharmacodynamic synergism Disorder ( ADHD ) medications are usually stimulants may be avoided Concerta Ritalin! Warranted, carefully observe the patient, particularly during treatment with an MAOI and also within a minimum of days!